Atlas FDA

INFUSE BONE GRAFT

FDA premarket approval P000054/S044 · decided 2016-09-16

Approval details

PMA number
P000054
Supplement
S044
Supplement type
Normal 180 Day Track
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
INFUSE BONE GRAFT
Generic name
Filler, recombinant human bone morphogenetic protein, collagen scaffold, osteoinduction
Applicant
Medtronic Sofamor Danek USA, Inc.
Date received
2016-06-21
Decision date
2016-09-16
Days to decision
87 days
Decision code
APPR
Product code
MPW
Advisory committee
Orthopedic
Expedited review
No
Location
Memphis, TN
Statement
Approval for increasing the size of the bioreactor used to manufacture rhBMP-2 from 6000 L to 12,000 L at the Pfizer Andover, MA Facility.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Catalyft PL Expandable Interbody System (K253011)Medtronic Sofamor Danek USA, Inc.2026-07-17
Symmetrix™ L Spinal System (K261020)Medtronic Sofamor Danek USA, Inc.2026-07-14
OsteoCool™ RF Ablation System; OsteoCool™ 2.0 RF Ablation System (K253656)Medtronic Sofamor Danek USA, Inc.2026-06-05
CD Horizon™ ModuLeX™ Fenestrated Screw Set; CD Horizon™ ModuLeX™ Spinal System (K260216)Medtronic Sofamor Danek USA, Inc.2026-04-21
Infinity™ OCT System (K254165)Medtronic Sofamor Danek USA, Inc.2026-01-21
CD Horizon™ ModuLeX™ Spinal System (LigaMAS Head Assembly) (K253941)Medtronic Sofamor Danek USA, Inc.2026-01-07
Infinity™ OCT System (K253129)Medtronic Sofamor Danek USA, Inc.2025-10-24
CD Horizon™ Spinal System (K253335)Medtronic Sofamor Danek USA, Inc.2025-10-24